MDGL   $343.42  4.27% Market Open

Madrigal Pharmaceuticals Inc
Total Cash 998.63M
totalCashPerShare 45.787
EBITDA -547.18M
Total Debt 119.14M
quickRatio 5.786
currentRatio 5.981
Total Revenue 76.81M
debtToEquity 15.33
Revenue/Share 3.705
ROA -0.52246
ROE -1.2976401
grossProfits
freeCashflow -263.11M
operatingCashflow -431.02M
earningsGrowth
revenueGrowth
grossMargins 0.96370006
ebitdaMargins 0.0
operatingMargins -1.8705901
profitMargins 0.0
enterpriseValue 6.48B
forwardPE -23.851904
floatShares 10.73M
sharesOutstanding 21.81M
sharesShort 4.05M
sharesShortPriorMonth 3.73M
dateShortInterest
sharesPercentSharesOut 0.19%
heldPercentInsiders 0.15%
heldPercentInstitutions 1.05%
Short Ratio help_outline 14.17%
shortPercentOfFloat 0.27%
impliedSharesOutstanding
bookValue 35.639
Price To Book help_outline 9.49
earningsQuarterlyGrowth
netIncomeToCommon -518.67M
trailingEps -25.02%
forwardEps -14.18%
enterpriseToEbitda -11.85
lastDividendValue
lastDividendDate
currentQuarterEstimate -4.49 4Q 2024
institutionsCount 354
lastUpdated Nov. 7, 2024, 3:20 a.m.